NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding NextCure, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 78 | 71 | −7 |
| Shares | 15.5M | 14.7M | −717.3K (−4.6%) |
| Value | $124.2M | $99.5M | −$24.7M (−19.9%) |
New holders (6)
Institutions that held NextCure, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Diametric Capital, LP | 76,162 | $513.0K | 0.40% |
| Prelude Capital Management, LLC | 61,407 | $414.0K | 0.02% |
| Susquehanna International Group, LLP | 59,907 | $404.0K | 0.00% |
| Algert Global LLC | 21,882 | $147.0K | 0.02% |
| Connor, Clark & Lunn Investment Management Ltd. | 14,756 | $99.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 550 | $4.00K | 0.00% |
Sold out (13)
Institutions that held NextCure, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| ArrowMark Colorado Holdings LLC | 228,855 | $1.84M |
| Charles Schwab Investment Management Inc | 60,870 | $489.0K |
| Tibra Equities Europe Ltd | 41,100 | $330.0K |
| Wellington Management Group LLP | 24,146 | $193.0K |
| Jump Financial, LLC | 16,769 | $135.0K |
| Jane Street Group, LLC | 15,124 | $121.0K |
| Gsa Capital Partners LLP | 14,125 | $113.0K |
| Assenagon Asset Management S.A. | 13,551 | $109.0K |
| Deutsche Bank AG | 7,111 | $57.0K |
| Panagora Asset Management Inc | 3,354 | $27.0K |
| US Bancorp | 392 | $3.00K |
| New York State Common Retirement Fund | 146 | $1.00K |
| Signaturefd, LLC | 94 | $1.00K |